Stampeding for the Exits: Pharmaceutical Companies and the Recent Wave of Inversions

Jul 21, 2014

Reading Time : 3 min

Furthermore, although the U.S. imposes tax on a domestic corporation’s worldwide income, the imposition of such tax is generally deferred until the corporation repatriates its active earnings from abroad. Many corporations, especially those in the pharmaceutical and technology industries, which often keep their intellectual property overseas, prefer to reinvest their earnings abroad indefinitely rather than repatriate and pay tax. Eventually, however, the amount of cash invested overseas builds up to such a level that shareholders force management to repatriate some of it to be distributed as a dividend. Apple’s famous tiff with Greenlight Capital is a notable example of this phenomenon. Inverting is one way to free such trapped cash without incurring additional tax. In certain circumstances, following the inversion such cash can be distributed by the foreign subsidiaries to the new foreign parent without subjecting the funds to U.S. taxation (even though such cash was accumulated during the period in which the foreign subsidiaries were held by the prior U.S. parent). Finally, the inversion allows the combined corporate group to further reduce its effective U.S. tax with respect to future income earned in the group’s remaining U.S. subsidiaries through the use of base-eroding payments from the U.S. subsidiaries to the foreign parent.

From a tax perspective the U.K. is a particularly attractive jurisdiction because of its extensive tax treaty network and lack of a dividend withholding tax on outbound dividends. It also has taxpayer-friendly rules relating to earnings earned outside the U.K. and the exploitation of intellectual property. There are non-tax reasons as well for choosing the U.K. or Ireland, such as their central location between the U.S. and Asia, highly skilled work force, common law legal system and membership in the European Union.

To be sure, certain hurdles must be cleared before the IRS respects an inversion. The first regulatory roadblock to inversions was set up in 1994 after Helen of Troy, a publicly traded U.S. cosmetics company, merged with the newly created U.S. subsidiary of a Bermuda company. The inversion prompted Treasury to amend the regulations under section 367(a) so that the transfer of stock of a domestic corporation by a U.S. person to a foreign corporation is taxable if the U.S. transferors own in aggregate 50% or more of either the total voting power or the total value of the stock of the transferee corporation immediately after the merger.

This outbound toll wasn’t much of an obstacle though, and a wave of inversions by oil and gas companies such as Transocean, Noble and Nabors led to the enactment of section 7874 in 2004. Under section 7874, an expatriated U.S. corporation will still be treated as a domestic corporation if the historical shareholders of the U.S. corporation own at least 80% of the new foreign corporation post-merger and the new corporation does not have “substantial business activities” in its new tax home as compared to the total business activities of the expanded affiliated group. A corporation has “substantial business activities” in a foreign country when at least 25% of its employees, assets and income are located or derived from the relevant foreign country. Furthermore, although the IRS will respect an inversion where the historical shareholders own less than 80% of the new corporation, if historical shareholders own 60% or more of the new corporation post-merger then the new corporation may be subject to significant penalties such as the taxation of built-in asset gain and limitations on the use of its tax attributes.

President Obama’s 2015 budget proposal and bills recently introduced in the House and Senate by Democratic lawmakers propose to tighten the requirements of section 7874. The proposals replace the 60% and 80% tests with a flat “greater than 50% test” such that the historical shareholders of the U.S. company may not own more than 49% of the new corporation after the merger if the inversion is to be respected by the IRS. The proposals also add a special rule that would ignore the inversion regardless of the level of ownership change if the company has substantial business activities in the United and is primarily managed and controlled from the United States after the merger.

In a letter to key lawmakers in the House and Senate, Jack Lew, the U.S. Secretary of the Treasury, called on Congress to “enact legislation immediately – and make it retroactive to May 2014 – to shut down” inversions. Retroactivity was also proposed when section 7874 was originally enacted, but ultimately section 7874 was only applied on a prospective basis.

Although it seems unlikely that the Democratic bills will actually be enacted, Republican lawmakers, specifically Senator Orrin Hatch, the ranking minority member on the Senate Finance Committee, recently expressed some willingness to enact some sort of reform to limit corporate inversions. It remains to be seen how far Republicans are willing to go.

Share This Insight

Categories

Previous Entries

Deal Diary

June 27, 2024

On June 24, 2024, the U.S. Securities and Exchange Commission (SEC) published five new Form 8-K Compliance and Disclosure Interpretations (C&DIs) expanding the agency’s interpretations of cybersecurity incident disclosures pursuant to Item 1.05 of Form 8-K. In July 2023, the SEC adopted final rules with respect to cybersecurity incidents that generally require public companies to disclose (i) material cybersecurity incidents within four business days after determining the incident was material and (ii) material information regarding their cybersecurity risk management, strategy and governance on an annual basis. We wrote about the final cybersecurity disclosure rules here.

...

Read More

Deal Diary

February 12, 2024

The Securities and Exchange Commission (SEC) recently adopted final rules (available here; also see the fact sheet and press release) representing significant changes to  special purpose acquisition companies (SPACs), shell companies and the disclosure of projections. These rules aim to enhance disclosures, protect investors and align the regulatory framework for SPACs with traditional IPOs. The following summarizes the key aspects of these rules.

...

Read More

Deal Diary

October 4, 2023

On September 20, 2023, the U.S. Securities and Exchange Commission (SEC) issued a final rule amending the so-called “Names Rule” (found here) that is “designed to modernize and enhance” protections under Rule 35d-1 of the Investment Company Act of 1940. The final rule is part of the SEC’s holistic efforts to regulate environmental, social and governance (ESG) matters, and is the SEC’s latest attempt to curb greenwashing in U.S. capital markets. The amendments require registered investment funds that include ESG factors in their names to place 80% of their assets in investments corresponding to those factors, thereby extending to ESG funds the SEC’s long-standing approach of regulating the names of registered funds to ensure they are marketed to investors truthfully. Fund complexes with more than $1 billion in assets will have two years from the final rule’s effective date (60 days after publication in the Federal Register) to comply, while fund complexes with less than $1 billion in assets will be given a compliance period of 30 months.

Chair Gary Gensler said “[t]he Names Rule reflects a basic idea: A fund’s investment portfolio should match a fund’s advertised investment focus. In essence, if a fund’s name suggests an investment focus, the fund in turn needs to invest shareholders’ dollars in a manner consistent with that investment focus. Otherwise, a fund’s portfolio might be inconsistent with what fund investors desired when selecting a fund based upon its name.” The sole dissenting vote against the rule modification, Commissioner Mark Uyeda, said “[w]ith these amendments, the Commission overemphasizes the importance of a fund’s name, as if to suggest that investors and their financial professionals need not look at the prospectus disclosures.” Commissioner Uyeda also expressed concern that fund investors will bear the increased compliance costs associated with the rule change.

...

Read More

Deal Diary

May 31, 2023

As discussed in our prior publication (found here), the Securities and Exchange Commission (SEC) adopted amendments on December 14, 2022, regarding Rule 10b5-1 insider trading plans and related disclosures. On May 25, 2023, the SEC issued three new compliance and disclosure interpretations (C&DIs) relating to the Rule 10b5-1 amendments.

...

Read More

Deal Diary

May 24, 2023

On May 15, 2023, the Eastern District of California ruled that California Assembly Bill No. 979 (“AB 979”) violates the Equal Protection Clause of the U.S. Constitution’s Fourteenth Amendment and 42 U.S.C. § 1981. As enacted, California’s Board Diversity Statute, required public companies with headquarters in the state to include a minimum number of directors from “underrepresented communities” or be subject to fines for violating the statute. AB 979 defines a “director from an underrepresented community” as “an individual who self-identifies as Black, African American, Hispanic, Latino, Asian, Pacific Islander, Native American, Native Hawaiian, or Alaska Native, or who self-identifies as gay, lesbian, bisexual, or transgender.”

...

Read More

Deal Diary

May 9, 2023

Update: On October 31, 2023, the Fifth Circuit granted the US Chamber of Commerce's petition for review of the SEC's share repurchase disclosure rules, holding that the SEC acted arbitrarily and capriciously in violation of the Administrative Procedure Act. The court directed the SEC to correct the defects within 30 days of the opinion. On December 1, 2023, the SEC informed the Fifth Circuit that it was unable to correct the rule's defects within 30 days of the opinion. On December 19, 2023, the Fifth Circuit vacated the SEC’s share repurchase disclosure rules.

...

Read More

Deal Diary

April 12, 2023

We have released our 2023 ESG Survey which includes a collection of reports reflecting on significant ESG themes and trends from 2022, as well as what we believe to be key developments for 2023.

...

Read More

Deal Diary

February 6, 2023

As companies begin preparing for the 2023 proxy season, we note that Institutional Shareholder Services Inc. (ISS) and Glass Lewis, the leading providers of corporate governance solutions and proxy advisory services, issued updated benchmark policies (proxy voting guidelines), which can be found here and here, respectively. The updated proxy voting guidelines generally focus on board accountability and oversight considerations and address topics such as climate accountability, board diversity, shareholder rights, corporate governance standards, executive compensation and social issues. What follows is a summary of the proxy voting guidelines published by ISS and Glass Lewis for the 2023 proxy season.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.